Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
D000293:Adolescent; D000328:Adult; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D008297:Male; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000008:administration & dosage / Q000627:therapeutic use*; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy*; D013871:Thiones; D013876:Thiophenes
D009600:Nitroquinolines; D011719:Pyrazines; D013871:Thiones; D013876:Thiophenes; D010073:Oxamniquine; C026209:oltipraz